FDA's Office of Operations (OO) provides leadership for operational activities, interaction and execution of program initiatives across the Office of the Commissioner (OC) and FDA centers, field offices and regions. OO assures that the conduct of agency administrative and financial management activities effectively support program operations.
The Chief Operating Officer (COO) has agency-wide authority for strengthening the management of business programs and operations of the agency. The COO oversees day-to-day management issues, effective implementation of Congressional and Commissioner priorities and initiatives, and the delivery of quality services by the agency and its centers.
OO provides an array of agency-wide services including information technology, procurement, and facilities. OO provides leadership and direction regarding delegation of authority, freedom of information, privacy act, and regulatory dockets management and ethics and conflict of interest matters. OO provides executive administrative management services to the OC nationwide staff.
Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress OO is making towards it's strategic priorities below:
OO Strategic Priorities
I. Building and Managing a Diverse Workforce (Office of Equal Employment Opportunity)
II. Emergency Response Measures (Office of Crises Management)
III. Preparedness Measures (Office of Crises Management)
A. Coordinate intra-agency and inter-agency activities related to crisis management and emergency preparedness and response including the agency's planning of, participation in and evaluation of exercises. Exercises will test FDA's ability to respond to crises and emergencies (e.g., FDA-, HHS-, and DHS Exercises).
Measures are under development and will be available once finalized.
I. Timeliness Measures (Office of Finance)
II. Competitive Contract Measures (Office of Acquisition)
III. Personal Identification Verification (PIV) Card Measures (Office of Security Operations)
IV. Discrimination Complaint Timeliness Measures (Office of Equal Employment Opportunity)
A. Provide FDA employees an efficient complaint processing system and encourage the early resolution of disputes through prevention and mediation in accordance with the U.S. Equal Employment Opportunity Commission's (EEOC) established timeframes.
V. Security Authorization Measures (Office of Information Management and Technology)
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.